OpenAI Explores Investment Opportunities in Korean Startups with Sam Altman

Date:

Sam Altman, co-founder and CEO of OpenAI, a US-based artificial intelligence (AI) technology firm, said he is interested in Korean startups using his company’s generative AI platform ChatGPT. During a recent meeting with 130 local startup leaders and journalists in Seoul, Altman mentioned that the US company is also exploring investment opportunities in Korean startups and the possibility of joint chip corporations to develop AI accelerators. OpenAI‘s generative AI service ChatGPT has been praised since its release last November, demonstrating AI‘s ability to influence daily life. Altman travelled to Europe, Israel, Japan, the United Arab Emirates, India, and Korea, part of his OpenAI Tour 2023, to talk with world leaders about AI and the possible threats the technology poses. OpenAI has shown interest in collaborating with not only Korean startups but also with major companies like Samsung Electronics, Hyundai Motor Group, and LG Electronics.

See also  Developers Now Able to Incorporate Generative AI with Amazon's Bedrock Cloud Service

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.